Skip to main content Skip to navigation
Purified Mouse anti-FADD (pS194)
558370_image1.png

Western blot analysis of FADD (pS194) in human epidermis. Lysates from control (lanes 1-3l) and calyculin A-plus-okadaic acid-treated (lanes 4-6) human A-431 epidermoid carcinoma were probed with purified mouse anti-FADD (pS194) monoclonal antibody at concentrations of 2.0 (lanes 1 and 4), 1.0 (lanes 2 and 5), and 0.5 µg/ml (lanes 3 and 6).  FADD (pS194) is identified as a band of 27 kDa in the treated cells.

Western blot analysis of FADD (pS194) in human epidermis. Lysates from control (lanes 1-3l) and calyculin A-plus-okadaic acid-treated (lanes 4-6) human A-431 epidermoid carcinoma were probed with purified mouse anti-FADD (pS194) monoclonal antibody at concentrations of 2.0 (lanes 1 and 4), 1.0 (lanes 2 and 5), and 0.5 µg/ml (lanes 3 and 6).  FADD (pS194) is identified as a band of 27 kDa in the treated cells.

Product Details
Down Arrow Up Arrow


BD Pharmingen™
Human (QC Testing)
Mouse BALB/c IgG1, κ
Phosphorylated peptide of the region including serine 194 of human FADD
Western blot (Routinely Tested)
27 kDa
0.5 mg/ml
AB_647274
Aqueous buffered solution containing ≤0.09% sodium azide.
RUO


Preparation And Storage

The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. Store undiluted at 4°C.

Product Notices

  1. Since applications vary, each investigator should titrate the reagent to obtain optimal results.
  2. Please refer to www.bdbiosciences.com/us/s/resources for technical protocols.
  3. Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.
558370 Rev. 2
Antibody Details
Down Arrow Up Arrow
J119-857.36

During apoptosis, cells exhibit morphological signs of the death process: cell shrinkage, membrane blebbing, and chromatin condensation.  The role of the cell surface cytokine receptor, Fas (Apo-1, CD95), in apoptosis has been well characterized.  The tumor necrosis factor (TNF) receptor type I (TNFRI, CD120a) and TNF-related apoptosis-inducing ligand receptor 2 (TRAILR2, DR5) can trigger cell death, as well as various other responses.  Fas, TNFRI, and TRAILR2 affect a common target in the cell death pathway, FADD (Fas-Associated via Death Domain or FAS-Associating protein with Death Domain, also known as MORT1).   FADD is an adaptor protein that specifically binds to Fas and other death domain-containing proteins via their homologous death domains.  FADD also contains an N-terminal Death Effector Domain (DED) that interacts with the DED-containing procaspases-8 and -10 to initiate apoptosis.  The role of FADD serine 194 (S194) phosphorylation in the regulation of apoptosis and cell cycle progression is under investigation.

The J119-857.36 monoclonal antibody recognizes the phosphorylated S194 of human FADD.

558370 Rev. 2
Format Details
Down Arrow Up Arrow
Purified
Tissue culture supernatant is purified by either protein A/G or affinity purification methods. Both methods yield antibody in solution that is free of most other soluble proteins, lipids, etc. This format provides pure antibody that is suitable for a number of downstream applications including: secondary labeling for flow cytometry or microscopy, ELISA, Western blot, etc.
Purified
558370 Rev.2
Citations & References
Down Arrow Up Arrow
View product citations for antibody "558370" on CiteAb

Development References (4)

  1. Alappat EC, Volkland J, Peter ME. Cell cycle effects by C-FADD depend on its C-terminal phosphorylation site. J Biol Chem. 2003; 278(43):41585-41588. (Biology).
  2. Hua ZC, Sohn SJ, Kang C, Cado D, Winoto A. A function of Fas-associated death domain protein in cell cycle progression localized to a single amino acid at its C-terminal region. Immunity. 2003; 18(4):513-521. (Biology).
  3. Tibbetts MD, Zheng L, Lenardo MJ. The death effector domain protein family: regulators of cellular homeostasis. Nat Immunol. 2003; 4(5):404-409. (Biology).
  4. Tourneur L, Buzyn A, Chiocchia G. FADD adaptor in cancer. Med Immunol. 2005; 4(1):1. (Biology).
View All (4) View Less
558370 Rev. 2

Please refer to Support Documents for Quality Certificates

 

Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described

 

Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims.  Comparisons are not made against non-BD technologies, unless otherwise noted.

For Research Use Only. Not for use in diagnostic or therapeutic procedures.